Novonesis provides outlook for 2024 with expected 5-7% organic sales growth and ~35% adj. EBITDA margin. Pro forma financials disclosed. Ester Baiget, CEO of Novonesis, said: “Today we provide key pro ...
Pro Forma Revenue (Non-GAAP): The figure of ~$1.67 million reflects ONAR’s internally prepared estimate of consolidated revenue as if JUICE had been owned for the entire Q3 2025 (“Pro Forma” meaning ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback